chr6-31762148-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_172166.4(MSH5):​c.2356C>T​(p.Pro786Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0233 in 1,614,030 control chromosomes in the GnomAD database, including 1,098 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.049 ( 341 hom., cov: 32)
Exomes 𝑓: 0.021 ( 757 hom. )

Consequence

MSH5
NM_172166.4 missense

Scores

2
13

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.02

Publications

23 publications found
Variant links:
Genes affected
MSH5 (HGNC:7328): (mutS homolog 5) This gene encodes a member of the mutS family of proteins that are involved in DNA mismatch repair and meiotic recombination. This protein is similar to a Saccharomyces cerevisiae protein that participates in segregation fidelity and crossing-over events during meiosis. This protein plays a role in promoting ionizing radiation-induced apoptosis. This protein forms hetero-oligomers with another member of this family, mutS homolog 4. Polymorphisms in this gene have been linked to various human diseases, including IgA deficiency, common variable immunodeficiency, and premature ovarian failure. Alternative splicing results multiple transcript variants. Read-through transcription also exists between this gene and the downstream chromosome 6 open reading frame 26 (C6orf26) gene. [provided by RefSeq, Feb 2011]
MSH5-SAPCD1 (HGNC:41994): (MSH5-SAPCD1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring mutS homolog 5 (MSH5) and chromosome 6 open reading frame 26 (C6orf26) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015169978).
BP6
Variant 6-31762148-C-T is Benign according to our data. Variant chr6-31762148-C-T is described in ClinVar as Benign. ClinVar VariationId is 3056743.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.112 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSH5NM_172166.4 linkc.2356C>T p.Pro786Ser missense_variant Exon 24 of 25 ENST00000375750.9 NP_751898.1 O43196-1A0A024RCM1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSH5ENST00000375750.9 linkc.2356C>T p.Pro786Ser missense_variant Exon 24 of 25 1 NM_172166.4 ENSP00000364903.3 O43196-1
MSH5-SAPCD1ENST00000493662.6 linkn.2407C>T non_coding_transcript_exon_variant Exon 24 of 29 1 ENSP00000417871.2 A0A024RCV8

Frequencies

GnomAD3 genomes
AF:
0.0491
AC:
7470
AN:
152104
Hom.:
341
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.115
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0546
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.00455
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.0510
Gnomad NFE
AF:
0.0191
Gnomad OTH
AF:
0.0703
GnomAD2 exomes
AF:
0.0298
AC:
7502
AN:
251442
AF XY:
0.0256
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.0532
Gnomad ASJ exome
AF:
0.109
Gnomad EAS exome
AF:
0.000489
Gnomad FIN exome
AF:
0.00222
Gnomad NFE exome
AF:
0.0194
Gnomad OTH exome
AF:
0.0381
GnomAD4 exome
AF:
0.0206
AC:
30176
AN:
1461808
Hom.:
757
Cov.:
32
AF XY:
0.0199
AC XY:
14450
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.116
AC:
3890
AN:
33474
American (AMR)
AF:
0.0537
AC:
2400
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.108
AC:
2819
AN:
26122
East Asian (EAS)
AF:
0.000554
AC:
22
AN:
39700
South Asian (SAS)
AF:
0.00468
AC:
404
AN:
86252
European-Finnish (FIN)
AF:
0.00217
AC:
116
AN:
53416
Middle Eastern (MID)
AF:
0.0479
AC:
276
AN:
5766
European-Non Finnish (NFE)
AF:
0.0165
AC:
18306
AN:
1111972
Other (OTH)
AF:
0.0322
AC:
1943
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
1521
3041
4562
6082
7603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0492
AC:
7485
AN:
152222
Hom.:
341
Cov.:
32
AF XY:
0.0468
AC XY:
3483
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.115
AC:
4758
AN:
41500
American (AMR)
AF:
0.0546
AC:
834
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
378
AN:
3470
East Asian (EAS)
AF:
0.00231
AC:
12
AN:
5186
South Asian (SAS)
AF:
0.00456
AC:
22
AN:
4828
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10618
Middle Eastern (MID)
AF:
0.0548
AC:
16
AN:
292
European-Non Finnish (NFE)
AF:
0.0191
AC:
1299
AN:
68020
Other (OTH)
AF:
0.0696
AC:
147
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
339
679
1018
1358
1697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0320
Hom.:
645
Bravo
AF:
0.0573
TwinsUK
AF:
0.0148
AC:
55
ALSPAC
AF:
0.0174
AC:
67
ESP6500AA
AF:
0.116
AC:
510
ESP6500EA
AF:
0.0217
AC:
187
ExAC
AF:
0.0289
AC:
3508
Asia WGS
AF:
0.0130
AC:
44
AN:
3478
EpiCase
AF:
0.0242
EpiControl
AF:
0.0260

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

MSH5-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.075
T;T;.;.;.;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.11
FATHMM_MKL
Benign
0.66
D
MetaRNN
Benign
0.0015
T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Uncertain
2.0
M;M;.;.;.;.
PhyloP100
1.0
PROVEAN
Benign
-0.54
N;N;N;N;N;N
REVEL
Benign
0.16
Sift
Benign
0.19
T;T;T;T;T;T
Sift4G
Benign
0.57
T;T;T;T;T;T
Polyphen
0.31
B;B;B;B;.;.
Vest4
0.099
MPC
0.59
ClinPred
0.0073
T
GERP RS
4.8
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.7
Varity_R
0.038
gMVP
0.34
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1802127; hg19: chr6-31729925; API